Fact based stock research
HCA (NYSE:HCA)


HCA stock research in summary

hcahealthcare.com


HCA shares have a SELL rating. They are bad value, show below average growth, and are riskily financed. We recommend selling HCA shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Facilities
Index S&P 500, D.J. US Health Care
Size class XX-Large

March 22, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()




Research History: HCA

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
46
68
67
44
STOCK GROWTH RANKS
20
46
29
29
STOCK SAFETY RANKS
13
18
7
19
COMBINED STOCK RANKS
3
32
1
14

Last update of Combined Rank: 22-Mar-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is HCA in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 22-Mar-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of HCA; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
40
47
27
28
PROFIT GROWTH
63
58
58
14
STOCK RETURNS
22
55
63
64
CONSOLIDATED RANK: GROWTH
20
46
29
29

Financial reporting date of Growth Rank: 31-Dec-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of HCA.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
10
2
1
2
REFINANCING
74
80
80
82
LIQUIDITY
21
27
33
33
CONSOLIDATED RANK: SAFETY
13
18
7
19

Financial reporting date of Safety Rank: 31-Dec-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of HCA and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for HCA from March 22, 2018.